Reply
Honored Contributor
Posts: 17,739
Registered: ‎03-09-2010

Most of us work hard @Trinity11. I think I make more insulin that other people , and that is a big help...If you DR is Ok with you hubby's numbers , he should also celebrate he is only a couple of points above , 5.7 so he is doing good ,without meds, or anything to help him

Honored Contributor
Posts: 17,739
Registered: ‎03-09-2010

A new study from McMaster and York universities has found that poor muscle health may be a complication of Type 1 diabetes, even among active twenty-somethings.

 

The research team analyzed muscle biopsies of young adults with and without Type 1 diabetes who exceed Diabetes Canada's recommended weekly levels for physical activity.

The researchers found structural and functional changes in the power generation parts of the cell, or mitochondria, of those with diabetes. Not only were the mitochondria less capable of producing energy for the muscle, they were also releasing high amounts of toxic reactive oxygen species, related to cell damage.

These changes could result in reduced metabolism, greater difficulty controlling blood glucose and, if left unchecked, an accelerated rate of developing disability. The study findings add poor muscle health to the list of better-known complications of Type 1 diabetes, including nerve damage, heart disease and kidney disorders.

"Now we know that even active people with diabetes have changes in their muscles that could impair their ability to manage blood sugar," said Thomas Hawke, corresponding author of the study and a professor of pathology and molecular medicine at McMaster. "Knowing in the long term that this could contribute to faster development of disability, we can start to address it early on."

Christopher Perry, study co-senior author and an associate professor in kinesiology and health sciences and the Muscle Health Research Centre at York University, added: "Skeletal muscle is our largest metabolic organ and is the primary tissue for clearing blood sugar after eating a meal, so we need to keep muscle as healthy as possible."

With regular aerobic exercise, the amount of mitochondria in muscle increases, thereby helping muscle cells to use more glucose and become more efficient. Given this new data, Perry added that their study suggests that current guidelines for Type 1 diabetics may also need to be revised.

"We believe these dysfunctional mitochondria are what's causing the muscle to not use glucose properly and to also damage muscle cells in the process. We were surprised to see the muscles were this unhealthy in young adults with Type 1 diabetes who were regularly active."

Researchers say while further study is needed, revising evidence-based exercise guidelines, specific for those with Type 1 diabetes, may be required to keep them in the best health.

The paper was published today in Diabetologia, the journal of the European Association for the Study of Diabetes. The study may be found at the link below.

The team included researchers at York University, the University of Windsor and the German Center for Neurodegenerative Diseases as well as McMaster's departments of pathology and molecular medicine, pediatrics and kinesiology. Both Hawke and Perry are on the Board of Directors for the Canadian Society for Exercise Physiology.

The study was funded in part by the Natural Sciences and Engineering Research Council of Canada, the Canada Foundation for Innovation, and the James H. Cummings Foundation.

Honored Contributor
Posts: 17,739
Registered: ‎03-09-2010

March 13, 2018 -- For decades, scientists have been working to understand not only the cause of diabetes but why the disease is increasing at an alarming rate. Surprisingly, a possible answer may lie right inside your pantry.

 

Folic acid, or vitamin B9, has been used to enrich bread, cereal, flour, cornmeal, pasta, rice and other grain products since the mid-1990s, when the U.S. Food and Drug Administration (FDA) required it as part of the Flour Fortification Initiative. A vital nutrient that supports many functions in the body, folic acid was added to help prevent birth defects in infants worldwide.

 

However, in populations where folic acid is readily available along with vitamin supplements, the additive might not be necessary and may actually be detrimental to people with particular genetic predispositions, according to published findings by Diabetes Research Institute scientists. In fact, excess consumption of folic acid may result in adverse health conditions and even cause the onset of autoimmune conditions, like type 1 diabetes (T1D), the study shows. 

 

 

U.S. incidence of diabetes over the past 50 years (type 1 and type 2) expressed as a % of total population. The red arrow depicts the initial point of mandatory fortification of flour products with folic acid. The green bars are measurements of serum folate levels from NHANES subjects of the corresponding years. 

“What was striking to us was the sudden uptick in the incidence of diabetes, nearly threefold the rate, in a few years following the mandatory fortification of flour in this country,” said Dr. Chris Fraker, research assistant professor of surgery and cell transplantation and co-author of the study published in Frontiers in Endocrinology. “Additionally, the serum levels of folate (metabolized folic acid) and non-metabolized folic acid measured in the blood of NHANES (National Health and Nutrition Examination Survey/Centers for Disease Control) study subjects were significantly increased.”

 

Folic Acid, Viruses and T1D: A Possible Connection?

 

Folic acid’s role as a possible trigger for the onset of type 1 diabetes became a target of increasing interest as Dr. Fraker, together with Dr. Allison Bayer, research assistant professor of microbiology and immunology and study co-author, furthered their ongoing research into natural killer (NK) cells, critical cells of the immune system that serve as the first line of defense against viruses and other harmful invaders.

Scientists throughout the diabetes field have established that viruses are a likely role player in the development of T1D. Viruses are known to cause problems in the immune system that lead to unchecked inflammation which, in turn, launches an improper response against “self” tissues, like insulin-producing cells.

 

Different viruses are prevalent in a large percentage of the population. They are passed down from generation to generation and go through cycles of activation and latency over one’s lifetime. Typically, the viruses do not pose a threat in the majority of people; if they did, they would be eliminated by the immune system.

 

But research has shown that in some people, like those at risk for autoimmune conditions, the viruses are able to gain a foothold in cells, escaping destruction and causing problems in the host immune system.

 

Drs. Fraker and Bayer have observed in their work, and supported by other studies, that NK cells are defective in people with type 1 diabetes and, as a result, viruses are capable of manipulating the immune response in their favor so as not to be destroyed. Getting to the bottom of how and why this happens led the researchers to some unexpected findings.

 

The Evidence Stacks Up

 

In examining the factors that influence the immune system, many environmental causes have been suggested over the past 20 years: diet, stress, sleep, and chemicals, to name a few. While these factors likely play a role, the majority of people still do not develop type 1 diabetes or other autoimmune conditions.

 

Upon further investigation, one dietary factor stood out: folic acid, which, the scientists have learned, is a powerful immune system modulator. When it enters cells as a synthetic vitamin, as in the case of flour supplementation, folic acid can slow down the metabolic machinery of the cells by 1,500 times relative to naturally occurring folate found in green vegetables or meat products. This can damage the immune machinery, according to the researchers.

 

“We believe that this metabolic factor may actually be causing a general weakening in people’s immune systems that, in a person that has a genetic susceptibility, may lead to the development of not only diabetes but other autoimmune conditions as well,” said Dr. Fraker.

 

Correcting Autoimmunity

 

What can people do if they have already eaten products enriched with folic acid?

 

“For correcting this condition, I don’t think there is a simple fix because of the fact that if it is related to folic acid and you’ve consumed this food, you may have already done the damage to the immune system. Viruses can be reactivated within your body and it’s very difficult to get those under control,” Dr. Fraker said.

 

The researchers are continuing their study of NK cells to learn more about the potential effect of folic acid on the cells’ function to develop strategies to combat it.

 

“The long-term goal is to find a way to correct these defects and reset the immune system, hopefully eliminating autoimmune responses in the process, as we work to develop a biological cure for type 1 diabetes,” said Dr. Fraker.

Honored Contributor
Posts: 17,739
Registered: ‎03-09-2010

The first human trials have begun of a fixed-dose combination drug of human insulin and pramlintide to help treat type 1 diabetes.

The drug is called BioChaperone Pramlintide, developed by biotechnology company Adocia, which aims to improve blood glucose levels following meals.

It combines Symlin (pramlintide), a synthetic version of the natural hormone amylin which can help improve postprandial blood sugars, and Adocia's BioChaperone technology, which helps to optimise the performance of drugs.

While insulin regulates glucose levels, amylin helps to suppress glucagon, but as type 1 diabetes progresses neither hormone is eventually secreted. By combining human insulin and the synthetic pramlintide drug, researchers hope to mimic the way amylin and insulin are secreted from pancreatic beta cells. 

Researchers also hope to fully realise the potential of Symlin, the only FDA-approved amylin analog drug to be used alongside insulin, which is not approved in the UK by the NHS.

While Symlin has helped improve HbA1c and induce weight lossin people with type 1 diabetes and type 2 diabetes when added to insulin therapy, patient adherence to both insulin and Symlin has shown to be poor. 

Adocia's BioChaperone technology will be directed to increase the effectiveness of pramlintide, making it easier to use for patients.

"By removing the adherence barrier presented by additional injections, we hope to fully realize the therapeutic potential of pramlintide for people with type 1 diabetes," said Dr. Stan Glezer, Adocia’s Chief Medical Officer.

In this new trial, 24 people with type 1 diabetes will be randomly assigned to BioChaperone Pramlintide in sequence with two other treatments, with safety, tolerance and blood glucose levels after meals among the primary objectives.

The study is expected to be completed towards the end of 2018.

Honored Contributor
Posts: 12,854
Registered: ‎11-16-2014

@cherrySome really excellent, new information in your posts today. Thank you so very much for all that you do.Heart

Trusted Contributor
Posts: 1,362
Registered: ‎06-13-2017

@cherry   Interesting stuff, I  was on symlin for a period of time. Had problems with a lot of nausea, but also it can make hypoglycemic episodes difficult to treat, which was my experience with it.  Also at the time I was using a lantus pen twice a day, covering meals with humalog three times a day and symlin three times a day. Total of 8 sq injections a day with  pens. I hope they can  tweek things to make it easier to take and maybe not as ill effects. I told my provider when I got fed up with it, that i was not going to continue with that reimine no matter who ordered it. His physician assistant got me on a pump and things have been so much better although pumps have a lot of disadvantages as well.

I hope for the generations to come there will be an answer . Advaces in the treatment of diabetes have been made but so slow . When I was a child I tested my sugar with  urine in a beeker and a tablet dropped in would change colors. Then came the dip sticks. I was well into my 20's when the first glucometes came out and they were for use in hospitals at the bedside, not for in home use. 

Honored Contributor
Posts: 17,739
Registered: ‎03-09-2010

With commentary by Elsayed Z. Soliman, M.D., MSc., M.S., study senior author and director of the epidemiological cardiology research center at Wake Forest Baptist Medical Center, Winston-Salem, North Carolina.

 

 

 

Not all heart attacks announce themselves with Hollywood-style crushing chest pain and a drenching, cold sweat. When researchers from Wake Forest Baptist Medical Center in Winston-Salem, North Carolina, checked the hearts and medical records of 9,498 people over nine years, they found1 nearly equal numbers of untreated, silent heart attacks and recognized heart attacks that had received medical attention.

 

A silent heart attack may be missed because the symptoms are mild or seem like another, less-urgent health issue – such as indigestion, heartburn, the flu, fatigue or an ache-y muscle – notes Elsayed Z. Soliman, M.D., MSc., M.S., study senior author and director of the epidemiological cardiology research center at Wake Forest Baptist Medical Center, Winston-Salem, North Carolina. “People may also decide not to go to the hospital if they’re not sure it’s a heart attack, or if the hospital is far away, they don’t have health insurance or are concerned about the cost of care,” Dr. Soliman told EndocrineWeb.com.

 

But in the study, published May 16 in the journal Circulation, that proved deadly. People who’d had silent heart attacks were three times more likely than those who hadn’t had a heart attack at all to die. Typically, people who’ve had a silent heart attack miss out on emergency care that can save heart muscle during a heart attack such as fast treatment with procedures that open blocked arteries in the heart. They may also miss out on stepped-up attention to blood pressure, cholesterol, diet, exercise and stress afterwards that lower risk for future problems.

 

Dr. Soliman says silent heart attacks are a particular concern for people with diabetes. High blood sugar, high blood pressure and cholesterol problems raise risk for heart events, but  nerve damage can make warning signs of an attack impossible to feel. “People with diabetes may have an impaired perception of chest pain, a key symptom that compels people to go to the hospital,” he says.

 

The study is part of the on-going Atherosclerosis Risk in Communities research project involving white and African-American volunteers from Maryland, Minnesota, Mississippi and North Carolina. Participants underwent electrocardiograms to measure electrical activity in the heart; abnormalities can signal that a silent heart attack has happened. Silent heart attacks seemed to be slightly more common in African-Americans than whites. They were also more common in men in general, but raised risk for future deaths more in women.

 

Once discovered, a silent heart attack needs aggressive treatment to prevent future attacks, Dr. Soliman says. “A silent heart attack is a heart attack,” he says. “Doctors need to help patients who have had a silent heart attack quit smoking, reduce their weight, control cholesterol and blood pressure and get more exercise.”

 

That doesn’t mean everyone needs an EKG. “If you are at high risk for a heart attack because you have diabetes, high blood pressure, high cholesterol, smoke or a family history of heart disease or sudden cardiac death, your doctor can determine whether or not you need one,” Dr. Soliman says. 

 

People at high risk for heart trouble due to diabetes and other factors should also pay attention to heart-attack symptoms that whisper instead of shouting – particularly unusual fatigue, shortness of breath or pain in the chest, shoulders, arms or back that come on during regular exercise or physical work. “Symptoms during activities you used to perform without any unusual sensations are important to watch for,” he says.

 

Honored Contributor
Posts: 17,739
Registered: ‎03-09-2010

Diabetes type 2 is caused by the pancreas not producing enough of the hormone insulin, according to the NHS.

 

Without enough insulin, the body struggles to convert sugar in the blood into useable energy.

 

Diabetes symptoms include blurred vision, urinating more often than normal, and having cuts or wounds that take longer to heal than normal.

 

Controlling your blood sugar is very important, as diabetes patients are more likely to develop life-threatening complications, including heart disease, strokes and vision loss.

 

But, you could lower your risk of high blood sugar by eating more plums, a nutritionist has claimed.

 

 Prevent high blood sugar with plums in your diet

Plums could help to prevent high blood sugar as they have a low glycaemic index, according to nutritionist Dr Josh Axe.

 

Foods with a low glycaemic index are better for diabetes patients, as it takes longer for them to break down into sugars in the body.

 

This lowers the risk of any blood sugar spikes.

 

Plums are also packed full of compounds that protect the body against insulin resistance, he added.

 

Soluble fibre in plums help the body to control blood sugar in patients, Axe said.

 

 

 

 

 

 

 

 

“Plums have a low glycaemic index, and plum extracts aid in the reduction of blood glucose and triglyceride levels in the body,” the nutritionist said.

 

“The presence of flavonoids is another plum benefit, because they protect the body against insulin resistance.

 

“It’s also the presence of soluble fibre in plums that helps normalise blood sugar levels and serves as a natural remedy for diabetes.

 

“Soluble fibre helps the stomach to empty at a slower rate, which affects blood sugar levels and has a beneficial effect on insulin sensitivity.

 

“This helps to control diabetes.”

 

 

You could also control your blood sugar by eating a healthy, balanced diet, and by taking regular exercise, the NHS said.

 

There’s nothing diabetes patients can’t eat, but you should limit the amount of sugar, fat and salt in your diet.

 

The best diets contain a wide range of foods, including fruit, vegetables and some starchy foods.

 

Keeping active will also help you to lower your blood sugar.

 

Aim for about two and a half hours of moderate exercise every week, it added.

Honored Contributor
Posts: 17,739
Registered: ‎03-09-2010

April 18 (UPI) -- In comparing three classes of medication for type 2 diabetes, researchers found one class, which includes the drugs Onglyza, Janumet and Januvia, did not reduce the risk of death.

 

Scientists from Imperial College London found that dipeptidyl peptidase inhibitors were not as effective as two others types when compared with a placebo: sodium-glucose cotransporter inhibitors, which include Jardiance and Invokana, and glucagon-like peptide agonists, which include Victoza, Byettea, Saxenda, Bydureon and Trulicity, and are used as injectablesTheir findings were published Tuesday in the Journal of the American Medical Association.

The researchers analyzed 236 trials involving 176,310 participatns, comparing all the drugs against each other, a placebo or no treatment at all. The three groups of drugs are among the top sellers for diabetes, according to FirePharma in 2016, including $2.3 billion in sales of Januvia, $984 million of Janumet, $2.1 billion of Victoza, $738 million of Trulicity and $1.3 billion of Inkokana.

The researchers found all of the drug classes lowered blood sugar levels, but only two types reduced the risk of death when compared with a placebo. The SGLT-2 inhibitor drugs were associated with a 20 percent reduction in risk of death, compared with a placebo pill or no medication, GLP-1 agonist drugs reduced the death risk by 18 percent and the DPP-4 inhibitor drugs weren't associated with a reduced risk of mortality.

"Type 2 diabetes has become a global epidemic, with more cases than ever before," leader author Dr Sean Zheng, a researcher at the National Heart and Lung Institute at Imperial, said in a press release. "The three drug classes assessed here are being increasingly prescribed, yet until now there have been no clinical trials studying how these drugs compare to each other, and which type of drug could be the best option for patients."

In type 2 diabetes, levels of sugar in the blood to become too high, usually because of a lack of insulin.

Aside from changes to diet and exercise, most people need medication to control blood sugar.

Metformi is the most commonly prescribed drug type 2 diabetes and first on the market for the condition, but the drug sometimes doesn't work or triggers side effects.

GLT-2 inhibitors increase the amount of sugar excreted by the body, and GLP-1 agonists and DPP-4 inhibitors increase natural insulin levels.

In the study, SGLT-2 inhibitor drugs were associated with a 21 percent reduction in risk of dying from a cardiovascular event such as a heart attack or stroke and GLP-1 agonist medication was associated with a 15 percent drop. There was no reduction in risk of death from a cardiovascular event for the drugs DPP-4 inhibitors.

The SGLT-2 inhibitor drugs were associated with significant reductions in risk of heart failure compared compared with the two other.

Zheng said further work is now needed to confirm these findings and there was no evidence that any of the treatments caused harm. In addition, he said because these drugs are relatively new, they only tracked participants for a few years.

"Our hope is that in the crowded market that is diabetes medications, patients and their doctors have the necessary information to allow them to make informed decisions about long-term treatment strategies," Zheng said.

Honored Contributor
Posts: 17,739
Registered: ‎03-09-2010

Sandy Hausman reports

Working with teams of scientists around the world, biomedical engineer Mete Civelek has confirmed a genetic cause for the belly fat that plagues some women.

 

 

Mete Civelek

CREDIT UVA DEPT. OF BIOMEDICAL ENGINEERING

"We discovered one stretch of DNA that effects the size of fat cells," he says, "and it makes them store more fat around their abdomen as opposed to their hips."

 

And it turns out those who have this genetic sequence are also at increased risk for Type II diabetes.

 

"If you are a woman who has inherited this gene from your mother, you’re at 28% higher risk compared to a man who inherited this risk gene from his father," he explains.

 

That was a surprise, Civelek says, because scientists had long thought genetic causes of diabetes were a function of insulin secretion from the pancreas.  Now that researchers know about this other link to diabetes, they can start thinking about a drug that could help to prevent or treat the disease.